Show simple item record

dc.contributor.authorThurman, A.J.
dc.contributor.authorEdgin, J.O.
dc.contributor.authorSherman, S.L.
dc.contributor.authorSterling, A.
dc.contributor.authorMcDuffie, A.
dc.contributor.authorBerry-Kravis, E.
dc.contributor.authorHamilton, D.
dc.contributor.authorAbbeduto, L.
dc.date.accessioned2021-06-17T01:09:45Z
dc.date.available2021-06-17T01:09:45Z
dc.date.issued2021
dc.identifier.citationThurman, A.J., Edgin, J.O., Sherman, S.L. et al. Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling. J Neurodevelop Disord 13, 13 (2021).
dc.identifier.issn1866-1947
dc.identifier.pmid33827417
dc.identifier.doi10.1186/s11689-021-09361-6
dc.identifier.urihttp://hdl.handle.net/10150/659960
dc.description.abstractBackground: The purpose of this study was to evaluate expressive language sampling (ELS) as a procedure for generating spoken language outcome measures for treatment research in Down syndrome (DS). We addressed (a) feasibility, (b) practice effects across two short-term administrations, (c) test-retest reliability across two short-term administrations, (d) convergent and discriminant construct validity, and (e) considered comparisons across the conversation and narration contexts. Method: Participants were 107 individuals with DS between 6 and 23 years of age who presented with intellectual disability (IQ < 70). The utility of ELS procedures designed to collect samples of spoken language in conversation and narration were evaluated separately. Variables of talkativeness, vocabulary, syntax, utterance planning, and articulation quality, derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers), were considered. A 4-week interval was used to assess practice effects and test-retest reliability. Standardized direct assessments and informant report measures were collected to evaluate construct validity of the ELS variables. Results: Low rates of noncompliance were observed; youth who were under 12 years of age, had phrase-level speech or less, and had a 4-year-old developmental level or less were at particular risk for experiencing difficulty completing the ELS procedures. Minimal practice effects and strong test-retest reliability across the 4-week test-retest interval was observed. The vocabulary, syntax, and speech intelligibility variables demonstrated strong convergent and discriminant validity. Although significant correlations were found between the variables derived from both the conversation and narration contexts, some differences were noted. Conclusion: The ELS procedures considered were feasible and yielded variables with adequate psychometric properties for most individuals with DS between 6 and 23 years old. That said, studies of outcome measures appropriate for individuals with DS with more limited spoken language skills are needed. Context differences were observed in ELS variables suggest that comprehensive evaluation of expressive language is likely best obtained when utilizing both contexts. © 2021, The Author(s).
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.rightsCopyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectClinical trials
dc.subjectDown syndrome
dc.subjectExpressive language
dc.subjectExpressive language sampling
dc.subjectOutcome measures
dc.subjectPsychometrics
dc.subjectTreatment
dc.titleSpoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language sampling
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Psychology, University of Arizona
dc.identifier.journalJournal of Neurodevelopmental Disorders
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal published version
dc.source.journaltitleJournal of Neurodevelopmental Disorders
refterms.dateFOA2021-06-17T01:09:45Z


Files in this item

Thumbnail
Name:
s11689-021-09361-6.pdf
Size:
674.0Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.
Except where otherwise noted, this item's license is described as Copyright © The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License.